Lol, yes this week for sure.

A lot of posters have been saying this for months/years now.

CEO needs to go otherwise nothing will happen for this company despite a good ip(s).

I think his intention is to say that the product I legit but the way the CEO is running this company does make it looks like a scam. PCTL will not get rid of him. Someone outside must be the one to do so.

At this point even the company can't do anything but wait on this. It's out of the Michael hands.

This board is the opposite of a pump board. Just saying.

Well this is financial week for many OTC who filed late. So there may have been better opportunities in other stocks?

I believe we got few weeks to another month before the N&S application hit the 6-month. I say this because it's just arbitrary deadline.

Have you guys seen any N&S application go beyond 6-month? Whether it was approve or deny? Just wondering how rare would it be for an N&S application to go 6+ months for a decision.

At this point, we need someone to replace the bumbling idiot as CEO.

It'll be nice to hear from the accountant and let him talk about 2021.

What a waste of potentials.

Agreed. We still have until tomorrow.

My post was meant more as a reply on the company's credibility if it doesn't happen by tomorrow and how this will affect the company's public exposure. It may or may not have any effect. Who knows. I didn't think my post would cause quite a stir LOL.

To me, if it doesn't happen by tomorrow so be it because we are dealing with the Government during a pandemic. There is no set timeline on N&S.

But I believe this may have an adverse effect (or vice versa) on the company's image as they confidently stated as such in the PR. Unlike the PRs with the drugs.

I believe this is big exchange ticker; thus, any PR with deadline is view as such IMO. I believe in Paul and so if no PR is out, which means he knows something.

Obviously you're missing the point of my post. If the company is going to be listed on the major exchange, credibility counts a lot. Unless they want to be stuck on the OCT forever.

Like I said i'm not disagreeing with you.

If the N&S doesn't happen within Q1 fine, send an updated PR to state that it will happen eventually. If you give a deadline, obviously you have to stick to it otherwise credibility will go down little by little.

I prefer them to just say we applied for the N&S and that's it. If it happens, it happens.

Not disagreeing but those who have talked to Paul stated that he has every reason to believe the N&S will happen by Q1. Thus; no updated PR to change deadline.

So if we have not seen a PR, which means he has every confident that a N&S will happen by tomorrow. If not, then yes there will be buying opportunities but also a little distrust in the company's ability to properly communicate.

I'm a long but this type of miscommunication or misstep can have a negative material effects on the company.

Ahh ok. It was interesting as the fund, the subject of the article, did say that the companies they invested in also focuses on several diseases including rabies.

Maybe i'm just reading too much into it.

Is he hinting at a potential partnership there with Adjuvant Capital? or just in passing?

Same. They wouldn't have come out with today's PR, if nothing is going to happen within a few days.

I'm thinking they may have already received noticed from FINRA but nothing official yet?

CTYX financial reports are on OTCMarket. You won't find these through the SEC. Not yet anyway. The new name change will change that going forward.

https://backend.otcmarkets.com/otcapi/company/financial-report/263700/content

Agreed. Anything under 1 bil would be great. Still if they are able to keep it at 724, that would be great. We'll find out next March I guess.

The calculation to 724MM....

They entered the year with 499 + 123 (based on this PR) + 35 (based on RB convertible), this would leave them with 67. Is this the dilution way back when?

If 724 is the true number, that is great; however, i don't feel like that is the case for some reason.

2 good thing comes out of this CPR.

1) the addition of the CPA makes me think that they're trying to uplist to a higher exchange.
2) the bridge funding for the initial development, so are they expecting a perm financing or some sort of capital coming which will pay this off? Bridge funding is usually short term; however, the warrants concern me. Also who is providing them the bridge note that requires management participation. This might be a good thing.

You make it sounds like it's a bad thing LOL

Oh interesting. I'll check tonight to see if it's up.

I was thinking we are due for a PR and given their last 2 on a Friday, we might see one tomorrow?

Now that I have time to digest the financials. Wow they just gave away 130 million shares for cheap. 100 mil for just $10k and 30 mil for just $3K?

The series C has a convertible rate of 30% of the total outstanding of common stock. Based on total outstanding of 323 million, that's about 97 million share. Based on the SP of $0.03, the entire series C is worth is $2.91 million today? This will be much higher in the future.

What services did the receiver(s) provide, which provides them with millions in returns?

I wonder who they issue that 100 million shares of Series A to (or it remains unissued) and half of Series C.

I must've missed something.

How is there dilution? Did you check with the TA?

Honestly I don't expect financials to show anything for awhile.

However, it's nice to see they keep up with filings even if there is nothing substantial.

Did they come out with the Q3? I know it doesnt change anything from Q2 but still would like to see it. Surprised that nothing is on edgar though or on OTC.

Unless we see some material change here?

Probably not but the trend is positive compared to historical.

If and when they get rid of the convertible and warrants and finally do what they said they will, this will see some light.

For now it's going to be a long 3 months for all longs.

Not sure how market will react to this financials.

On the one hand, it's an improvement over last year. On the other hand, it's a lackluster based on the CEO previous PRs.

Will we have good news tomorrow on the OTCQB?

It doesn't matter how well the company do compared to last year.

It's what the CEO has been stating through his PRs since Q1 of this year. He hasn't been consistent. It's going to bleed tomorrow.

Did they have a partnership and an investor tab before? I know someone mentioned a patient tab but I haven't check it for awhile now.

Here is what i'm afraid of. NT 10-Q file on Tuesday.

Also a run then a dip. same as before.

The new Q won't reflect declining (or hopefully wiped warrants). The majority of the warrants being wiped out occurred in Q4. So this won't be reflected until 2021.

It's because there is higher chance of hitting that with the PRV. If they sell it even at the lowest, this thing could be easily .10. However, the run-down back to 0.01 even after all the news hit? Not likely barring some extra-ordinarily negative events.

Yep thanks FAI

With this news, why is people willing to sell for 0.03?

Potential for this is at least 0.05 minimum!

LOL. Love it! Fluff, yeah right. Flippers trying to keep this down to get in lol.

PR with NIH + the Voucher. Awesome!!!

Like some poster stated. Here's my calculation using the chart with $2 billion in settlement. Please check the math:

Litigation Proceeds: $2 billion
Litigation Financing Principal: $5.95 million
Litigation % Return (5x or 25% of gross): $500 mil
Attorney Fees (25% of gross): $500 mil
IPNav Return (22% of gross): $440 mil
CBV Preference (100% of net up to $1 mil: $1 mil

Which would leave $553.05 million for CBV (50% of net) and Chanbond (50% of net). Unless i'm missing a party of something?

So my question is why this lawsuit? what are we missing in the lawsuit? Is Chanbond us (the common shareholder) and Billy? Any other reasons arise from this lawsuit beside the licensing?

How do Billy benefits from dilution, screwing us over or any #s of issues.

This was posted previously but got deleted for some reason.

I have been in this one since 2018 also but I never talk and just follow the board. I combed through the whole lawsuit and I am not a legal expert so if someone could help out, that would be great! I see couple issues and would like some opinions here:

1) Deidre lawsuit recommends several actions by issue one or more alternative relief: including rescinding the ISA and return prior to agreement, award damages, award judgement and/or comply with anti-assignment clause of the ISA. - Exhibit A of the PDF. So does that mean that there are options to remedy the situation without having to rescinding the ISA agreement?

2) The revised "waterfall chart" shows the following:

Bentham 22.5% - 25%
Mischcon 15% - 28.5%
IPNav 22% - 22%
CBV 50% of remainder
Unified/Chanbond Remainder 20.75% - 12.25%
UO! IP Share 20% - 20%
Unified net 16.4% - 9.8%

The $50 mil example shows that no one aside from the financing litigation, attorney and IPNav will get $$$. Since IPNav will be the last party to get any $$$ amount and everyone else including the inventors under CBV are short-changed.

Unless like some has stated that he diluted his shares already which is not that much compared to the potential from the settlement.

Here is where I'm confused. How do Billy benefits from this? I don't see him earning any money unless he's part of IPNav or the litigation financing party. Since pretty much the inventors and everyone under IPNav has a zero return on investment??? Why do Diedre file this lawsuit since she would get money under IPNav as well???

My concern is Billy is with 1) with the litigation party and pretty much short change all of us including the inventors or 2) he and Diedre is with IPNav and they're trying to rescind the agreement to benefit just the both of them.

I'm not a legal expert so opinions are needed. However, I do agree that we need a lawyer.

LOL. I totally misquote that.

Still though, this should be higher than the current cap. The potential for IMT504 alone even without PRV should be a lot higher.

They won't talk about COVID-19. They can but won't because of scrutiny by the SEC on stock trying to take advantage of it.

Until they have government approval. That's when I think they can talk about the potential for Covid-19 application.

I agree. Why sell at this level? The news should bring confidence up. If they want to take a profit, why not 4 cents or even 5 cents. Seems realistic with this measly market cap. The PR also stated that each voucher is worth in the $80-$150 million, so one would expect this voucher to be worth this much as well but market cap is still tiny.

Yep. Next week maybe? That would be awesome